ARVO
Membership Organizations · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5515 Security Ln Ste 500, Rockville, Mar...Phone Number
(240) 221-2900Website
www.arvo.orgRevenue
$9.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
2
3
2
1
About ARVO
The Association for Research in Vision and Ophthalmology (ARVO) is dedicated to advancing research in vision and ophthalmology. It offers a variety of resources including educational programs, funding opportunities, and advocacy initiatives aimed at eye and vision health professionals. ARVO serves a diverse membership, including early-career researchers and professionals in the ophthalmology field. Through its journals, annual meetings, and mentorship programs, ARVO supports collaboration and development within the global scientific community.Explore more
ARVO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ARVO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when ARVO launches new products
Check out if ARVO is spiking on competitors!
ARVO, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if ARVO had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ARVO
Website visits: Recent activity has been detected on your website
Check if ARVO has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ARVO has new funding data
Earning: See what the market has to say on ARVO recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ARVO
Compare insights from companies similar to ARVO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ARVO is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
ARVO is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about ARVO.
ARVO Tech Stack
A closer look at the technologies used by ARVO
ARVO News & Media
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal DiseasesBeacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting
LONDON and CAMBRIDGE, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and prevalent ocular diseases, today announced a 12-month safety and efficacy update from its Phase 2 DAWN trial evaluating the Company’s lead program, laruparetigene zovaparvovec (laru-zova), in patients with XLRP in a presentation at the Association foMingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
GUANGZHOU, China, May 5, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II clinical trial of QA102 in patients with...MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II clinical trial of QA102 in patients with...
Read more news
Top Membership Organizations Companies
Frequently Asked Questions Regarding ARVO
Sign Up For FreeTo access detailed company insights
The Association for Research in Vision and Ophthalmology (ARVO) is dedicated to advancing research in vision and ophthalmology. It offers a variety of resources including educational programs, funding opportunities, and advocacy initiatives aimed at eye and vision health professionals. ARVO serves a diverse membership, including early-career resear... Read More
